Intermountain Health Research Study Finds AI Technology is
Intermountain Health Research Study Finds AI Technology is
Publish Date: 2026-06-02 17:33:00
Source Domain: www.globenewswire.com
SALT LAKE CITY, June 02, 2026 (GLOBE NEWSWIRE) —
INTERMOUNTAIN NEWS RELEASE
B-Roll Video:
Available upon request
For Release:
June 2, 2026
Contact:
Jess Gomez: [email protected] / 801-718-8495
Intermountain Health Research Study Finds AI Technology is a ‘Game Changer’ for the Treatment of Two of the Most Common Chronic Pulmonary Conditions in the World
SALT LAKE CITY — A groundbreaking new study by researchers at Intermountain Health and CareCentra finds that implementing new AI technology to streamline and enhance care for two of the most common chronic pulmonary conditions in the world – including one that affects 1 of every 13 adults in the United States – resulted in a 50 percent drop in hospitalizations, 20 percent fewer emergency department visits, and a 57% reduction in overall costs.
Intermountain researchers say the study is a “game changer” for the care of the millions of patients with chronic obstructive pulmonary disease (COPD) and asthma, two of the most common chronic respiratory conditions in the world that cost more than $50 billion to treat per year in the United States – much of it spent on hospitalizations that could be prevented.
Researchers say the most concerning moments for doctors treating patients with chronic lung disease are not hospitalizations. It’s the silence between patient visits – weeks or months in which risk accumulates invisibly, unmonitored, until the next crisis arrives.
Researchers from Intermountain Health and CareCentra set out to end that silence utilizing AI technology to help monitor patients between visits and improve care for patients with COPD and asthma.
In the two-year study, researchers found that continuous, AI-driven monitoring of patients resulted in reduced total cost…
